FDA Inspection 988235 — GlaxoSmithKline LLC
The FDA completed an inspection of GlaxoSmithKline LLC on Jul 15, 2016 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 15, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)